Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac Conditions.

[1]  K. Thygesen,et al.  Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated Troponins. , 2016, The American journal of medicine.

[2]  A. Jaffe,et al.  Sensitive Troponin Assay and the Classification of Myocardial Infarction , 2015, The American journal of medicine.

[3]  M. Sebbane,et al.  Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis. , 2015, American heart journal.

[4]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[5]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[6]  D. Otten.  Elevated Cardiac Troponin T Levels in Critically Ill Patients with Sepsis , 2014 .

[7]  M. Nybo,et al.  Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarction. , 2014, Interactive cardiovascular and thoracic surgery.

[8]  J. Hallas,et al.  Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. , 2014, The American journal of medicine.

[9]  A. Exadaktylos,et al.  Non-acute myocardial infarction-related causes of elevated high-sensitive troponin T in the emergency room: a cross-sectional analysis , 2014, Internal and Emergency Medicine.

[10]  O. Nielsen,et al.  Troponin T is a strong marker of mortality in hospitalized patients. , 2013, International journal of cardiology.

[11]  J. Hallas,et al.  Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. , 2013, The American journal of medicine.

[12]  A. Jaffe,et al.  Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population , 2013, European heart journal. Acute cardiovascular care.

[13]  A. Jaffe,et al.  Preparing the United States for high-sensitivity cardiac troponin assays. , 2013, Journal of the American College of Cardiology.

[14]  G. Viviani,et al.  Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation. , 2013, The American journal of emergency medicine.

[15]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[16]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care , 2012 .

[17]  K. Thygesen,et al.  Discordant Diagnoses of Acute Myocardial Infarction due to the Different Use of Assays and Cut-Off Points of Cardiac Troponins , 2012, Cardiology.

[18]  B. Bouma,et al.  Predictors and Prognostic Value of Myocardial Injury During Transcatheter Aortic Valve Implantation , 2012, Circulation. Cardiovascular interventions.

[19]  R. Twerenbold,et al.  Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. , 2012, The American journal of medicine.

[20]  Matthew Taecker.  Outcomes of Hospitalized Patients with Non-acute Coronary Syndrome and Elevated Cardiac Troponin Level , 2012 .

[21]  A. Jaffe,et al.  Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. , 2011, Journal of the American College of Cardiology.

[22]  C. Pedersen,et al.  The Danish Civil Registration System , 2011, Scandinavian journal of public health.

[23]  Michael Freese,et al.  Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. , 2011, European heart journal.

[24]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[25]  H. Katus,et al.  Troponin elevation in coronary vs. non-coronary disease. , 2011, European heart journal.

[26]  M. Zhan,et al.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.

[27]  A. Jaffe,et al.  Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease. , 2010, The American journal of medicine.

[28]  S. de Servi,et al.  Prognostic Value of Isolated Troponin I Elevation After Percutaneous Coronary Intervention , 2010, Circulation. Cardiovascular interventions.

[29]  Christopher M O'Connor,et al.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. , 2010, Journal of the American College of Cardiology.

[30]  J. Nordrehaug,et al.  Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms. , 2010, The American journal of cardiology.

[31]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[32]  H. Bøtker,et al.  Existing data sources for clinical epidemiology: The Western Denmark Heart Registry , 2010, Clinical epidemiology.

[33]  A. Jaffe,et al.  Analytical validation of a high-sensitivity cardiac troponin T assay. , 2010, Clinical chemistry.

[34]  K. Nikus,et al.  The etiology and prognostic significance of cardiac troponin I elevation in unselected emergency department patients. , 2010, The Journal of emergency medicine.

[35]  R. Christenson,et al.  Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. , 2009, Clinical chemistry.

[36]  Waqas Aftab,et al.  Frequency of elevated troponin I and diagnosis of acute myocardial infarction. , 2009, The American journal of cardiology.

[37]  W. Markiewicz,et al.  Cardiac troponin I elevation in hospitalized patients without acute coronary syndromes. , 2008, The American journal of cardiology.

[38]  Bekele Afessa,et al.  Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients , 2008, Critical care medicine.

[39]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[40]  Hugo A Katus,et al.  Differential diagnosis of elevated troponins , 2006, Heart.

[41]  T. Fehr,et al.  Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. , 2006, Chest.

[42]  H. Schneider,et al.  Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay. , 2006, Clinical chemistry.

[43]  A. Levin,et al.  Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis , 2005, Circulation.

[44]  T. Sacchi,et al.  Elevated serum cardiac troponin I in rhabdomyolysis. , 2004, International journal of cardiology.

[45]  M. Volmer,et al.  Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. , 2001, Clinical chemistry.

[46]  R. Bonow,et al.  Chronic heart failure in the United States: a manifestation of coronary artery disease. , 1998, Circulation.

[47]  G. Toubin,et al.  Use of cardiac troponin I as a marker of perioperative myocardial ischemia. , 1995, The Annals of thoracic surgery.